| Literature DB >> 11008259 |
T Balslev1, P Uldall, J Buchholt.
Abstract
Three girls, two aged 12 years and one aged 17 years with refractory localization-related epilepsy were treated on an add-on basis with tiagabine. At dosages 22.5-30 mg/day (0.45-0.57 mg/kg/day) longstanding non-convulsive status epilepticus was noted in all three patients. The events of non-convulsive status epilepticus subsided following reduction in tiagabine dosages. In two cases, tiagabine was withdrawn, whereas it was continued at a lower dosage in one case. This is the first report of non-convulsive status epilepticus provoked by tiagabine in adolescent patients. Copyright 2000 European Paediatric Neurology Society.Entities:
Mesh:
Substances:
Year: 2000 PMID: 11008259 DOI: 10.1053/ejpn.2000.0293
Source DB: PubMed Journal: Eur J Paediatr Neurol ISSN: 1090-3798 Impact factor: 3.140